These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19857317)

  • 1. [New influenza A (H1N1): advised indication and prescription of antiviral drugs].
    van den Wijngaard CC; van Steenbergen JE; van der Sande MA; Koopmans MP
    Ned Tijdschr Geneeskd; 2009; 153():A1053. PubMed ID: 19857317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.
    Kawai N; Ikematsu H; Hirotsu N; Maeda T; Kawashima T; Tanaka O; Yamauchi S; Kawamura K; Matsuura S; Nishimura M; Iwaki N; Kashiwagi S
    Clin Infect Dis; 2009 Dec; 49(12):1828-35. PubMed ID: 19911968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of antiviral agents for the management of severe influenza.
    Smith JR; Ariano RE; Toovey S
    Crit Care Med; 2010 Apr; 38(4 Suppl):e43-51. PubMed ID: 19935416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oseltamivir-induced resistant pandemic A/H1N1 influenza virus in a child with cystic fibrosis and Pseudomonas aeruginosa infection.
    Esposito S; Molteni CG; Colombo C; Daleno C; Daccò V; Lackenby A; Principi N
    J Clin Virol; 2010 May; 48(1):62-5. PubMed ID: 20335065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis--North Carolina, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Sep; 58(35):969-72. PubMed ID: 19745803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fatal pneumonitis due to oseltamivir-resistant new influenza A(H1N1) in the case of an intensive care patient].
    Aardema H; Tulleken JE; van den Biggelaar RJ; Wolters BA; de Jager CM; Boucher CA; Riezebos-Brilman A
    Ned Tijdschr Geneeskd; 2010; 154():A1634. PubMed ID: 20482913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus.
    Wang SQ; Du QS; Huang RB; Zhang DW; Chou KC
    Biochem Biophys Res Commun; 2009 Aug; 386(3):432-6. PubMed ID: 19523442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the clinical effectiveness of oseltamivir and zanamivir against influenza virus infection in children.
    Sugaya N; Tamura D; Yamazaki M; Ichikawa M; Kawakami C; Kawaoka Y; Mitamura K
    Clin Infect Dis; 2008 Aug; 47(3):339-45. PubMed ID: 18582202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Naturally occurring oseltamivir resistance in influenza A].
    Madsen L; Nielsen A; Lundgren J
    Ugeskr Laeger; 2010 Aug; 172(32):2165-7. PubMed ID: 20696118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamiflu: what dermatologists need to know.
    Bergstrom KG
    J Drugs Dermatol; 2010 Jan; 9(1):76-8. PubMed ID: 20120431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effectiveness of Zanamivir and Oseltamivir against influenza A/H1N1, A/H3N2, and B.
    Kawai N; Ikematsu H; Iwaki N; Maeda T; Kawashima T; Hirotsu N; Kashiwagi S
    Clin Infect Dis; 2009 Apr; 48(7):996-7. PubMed ID: 19260819
    [No Abstract]   [Full Text] [Related]  

  • 13. Swine flu outbreak. What role for antiviral drugs?
    Couzin-Frankel J
    Science; 2009 May; 324(5928):705. PubMed ID: 19423784
    [No Abstract]   [Full Text] [Related]  

  • 14. Intravenous zanamivir in critically ill patients due to pandemic 2009 (H1N1) influenza A virus.
    Wijaya L; Chua YY; Cui L; Chan K; Tan BH
    Singapore Med J; 2011 Jul; 52(7):481-5. PubMed ID: 21808957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDA notifications. EUA issued for treating novel 2009 H1N1 flu.
    AIDS Alert; 2009 Jun; 24(6):69-70. PubMed ID: 19544608
    [No Abstract]   [Full Text] [Related]  

  • 16. Antivirals and influenza: frequency of resistance.
    Monto AS
    Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S110-2. PubMed ID: 18820569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of neuropsychiatric adverse events in influenza patients treated with oseltamivir or no antiviral treatment.
    Smith JR; Sacks S
    Int J Clin Pract; 2009 Apr; 63(4):596-605. PubMed ID: 19335705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oseltamivir: new indication. Prevention of influenza in at-risk children: vaccination is best.
    Prescrire Int; 2007 Feb; 16(87):9-11. PubMed ID: 17323516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. More resistance to oseltamivir (Tamiflu).
    Med Lett Drugs Ther; 2009 Jan; 51(1304):5-6. PubMed ID: 19172138
    [No Abstract]   [Full Text] [Related]  

  • 20. Oseltamivir and early deterioration leading to death: a proportional mortality study for 2009A/H1N1 influenza.
    Hama R; Jones M; Okushima H; Kitao M; Noda N; Hayashi K; Sakaguchi K
    Int J Risk Saf Med; 2011; 23(4):201-15. PubMed ID: 22156085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.